Gudrun Anstren

Gudrun Anstren has extensive experience in the pharmaceutical industry, highlighted by a career at AstraZeneca from April 1982 to December 2019, where numerous senior roles in product and project leadership were held across diverse therapeutic areas, including cardiovascular disease, diabetes, respiratory issues, oncology, and neurology. Gudrun Anstren has served as a board member at Stayble Therapeutics since June 2021 and at WntResearch AB since May 2018, in addition to leading Egenföretagare as CEO since February 2018. Academic credentials include a Master's degree in Pharmaceutical Sciences from Uppsala University, obtained between 1975 and 1980.